Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of EUR 92.24 billion. The enterprise value is 105.23 billion.

Market Cap	92.24B
Enterprise Value	105.23B

Important Dates

The next confirmed earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.43%
Shares Change (QoQ)	-0.44%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	49.62%
Float	1.08B

Valuation Ratios

The trailing PE ratio is 11.81 and the forward PE ratio is 9.16.

PE Ratio	11.81
Forward PE	9.16
PS Ratio	1.97
PB Ratio	1.29
P/TBV Ratio	7.35
P/FCF Ratio	10.26
P/OCF Ratio	8.58
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.25, with an EV/FCF ratio of 11.71.

EV / Earnings	13.47
EV / Sales	2.25
EV / EBITDA	8.25
EV / EBIT	11.08
EV / FCF	11.71

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.28.

Current Ratio	1.09
Quick Ratio	0.66
Debt / Equity	0.28
Debt / EBITDA	1.58
Debt / FCF	2.26
Interest Coverage	18.17

Financial Efficiency

Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 9.35%.

Return on Equity (ROE)	6.66%
Return on Assets (ROA)	4.65%
Return on Invested Capital (ROIC)	9.35%
Return on Capital Employed (ROCE)	9.80%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	624,162
Profits Per Employee	104,388
Employee Count	74,846
Asset Turnover	0.36
Inventory Turnover	1.32

Taxes

In the past 12 months, Sanofi has paid 1.04 billion in taxes.

Income Tax	1.04B
Effective Tax Rate	17.33%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sanofi had revenue of EUR 46.72 billion and earned 7.81 billion in profits. Earnings per share was 6.37.

Revenue	46.72B
Gross Profit	33.79B
Operating Income	9.65B
Pretax Income	6.02B
Net Income	7.81B
EBITDA	12.64B
EBIT	9.65B
Earnings Per Share (EPS)	6.37

Balance Sheet

The company has 7.67 billion in cash and 20.33 billion in debt, with a net cash position of -12.66 billion.

Cash & Cash Equivalents	7.67B
Total Debt	20.33B
Net Cash	-12.66B
Net Cash Per Share	n/a
Equity (Book Value)	71.71B
Book Value Per Share	59.10
Working Capital	2.61B

Cash Flow

In the last 12 months, operating cash flow was 10.75 billion and capital expenditures -1.76 billion, giving a free cash flow of 8.99 billion.

Operating Cash Flow	10.75B
Capital Expenditures	-1.76B
Free Cash Flow	8.99B
FCF Per Share	n/a

Margins

Gross margin is 72.34%, with operating and profit margins of 20.66% and 16.72%.

Gross Margin	72.34%
Operating Margin	20.66%
Pretax Margin	12.89%
Profit Margin	16.72%
EBITDA Margin	27.05%
EBIT Margin	20.66%
FCF Margin	19.24%

Dividends & Yields

Sanofi does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	61.08%
Buyback Yield	2.43%
Shareholder Yield	2.43%
Earnings Yield	8.47%
FCF Yield	9.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6